NICOrelief 2 mg Chewing Gum
RxNorm 605818
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 605818 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: NICOrelief 2 mg Chewing Gum.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Nicorelief 2 mg (nicotine polacrilex 22.2 mg) Chewing Gum
(Atom ID: 4619163)
PSNPrescribable
Prescribable Name (PSN):
NICOrelief 2 mg Chewing Gum
(Atom ID: 6361721)
SYPrescribable
Synonym (SY):
Nicorelief 2 mg Chewing Gum
(Atom ID: 2382904)
SBDPrescribable
Semantic Branded Drug (SBD):
Nicotine 2 mg Chewing Gum [Nicorelief]
(Atom ID: 12357716)
Patient Education
Nicotine Gum
Nicotine chewing gum is used to help people stop smoking cigarettes. Nicotine chewing gum should be used together with a smoking cessation program, which may include support groups, counseling, or specific behavioral change techniques. Nicotine gum is in a class of medications called smoking cessation aids. It works by providing nicotine to your body to decrease the withdrawal symptoms experienced when smoking is stopped and as a substitute oral activity to reduce the urge to smoke.
[Learn More]
* Please review the disclaimer below.